Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 14, 2025 • 7:00 PM ET

Date/Time Source News Release
03/25/2025 07:00 AM EDT GlobeNewswire Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now
02/19/2025 06:00 AM EST GlobeNewswire Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now
01/15/2025 07:00 AM EST GlobeNewswire Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now
12/09/2024 09:00 AM EST GlobeNewswire GeoVax Receives Notice of Allowance For Cancer Vaccine Patent
11/26/2024 09:00 AM EST GlobeNewswire GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference
11/19/2024 09:00 AM EST GlobeNewswire GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
11/12/2024 04:00 PM EST GlobeNewswire GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update
11/05/2024 09:00 AM EST GlobeNewswire GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024
10/02/2024 09:00 AM EDT GlobeNewswire GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
09/24/2024 07:00 AM EDT GlobeNewswire Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now
Page

Additional News

As of June 14, 2025 • 7:00 PM ET

Date/Time Source News Release
06/12/2025 09:06 AM EDT NewMediaWire GeoVax to Participate in BIO International Convention 2025
06/11/2025 09:07 AM EDT NewMediaWire GeoVax Responds to WHO's Fourth Declaration of Mpox as a Global Public Health Emergency
06/10/2025 09:06 AM EDT NewMediaWire GeoVax Announces Upcoming Presentation at the European Hematology Association 2025 Congress Highlighting Positive Immune Response Data for GEO-CM04S1 in CLL Patients
06/09/2025 09:06 AM EDT NewMediaWire GeoVax Highlights Broad Cross-Protective Immunity of Multi-Antigen COVID-19 Vaccine Candidates at Keystone Symposia
06/04/2025 09:05 AM EDT NewMediaWire GeoVax to Showcase Innovative COVID 19 Vaccine Data at the Keystone Symposia on Vaccinology
05/29/2025 09:06 AM EDT NewMediaWire GeoVax Congratulates Bipartisan Senate Action to Onshore Critical Medical Manufacturing
05/27/2025 11:06 AM EDT NewMediaWire GeoVax Commends FDA's Shift to Risk-Based COVID-19 Vaccination Guidance
05/21/2025 09:04 AM EDT NewMediaWire GeoVax Applauds EQUIP-A-Pharma Initiative, Reinforces Commitment to Domestic Vaccine Manufacturing and Biodefense Innovation
05/20/2025 09:07 AM EDT NewMediaWire GeoVax Reaffirms Urgent Need for Multi-Antigen COVID-19 Vaccines as CDC Shifts Recommendations
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.